Longitudinal Visit Timing And Slope Identifiability

Why Visit Timing Matters

A study may collect several biomarker measurements from each participant and still provide little information about how the biomarker changes over time. The key is not only the number of measurements, but also how far apart in time they occur. If visits cluster near baseline, a small amount of measurement noise can obscure the change between them. This matters especially when a joint model links event risk to a participant’s underlying biomarker slope: uncertainty about the slope can weaken estimation of that association.

The assessment here is about the longitudinal design’s support for slopes. It does not, by itself, establish that a slope-based survival association is well identified: information from event outcomes and the survival model also matters. The earlier material on structural and practical identifiability and shared random-effects association parameters provides that broader context.

Model and Assumptions

Definition: For participant $i$, let $Y_{ij}$ be the biomarker measured at time $t_{ij}$, measured from a specified time origin. A random-intercept, random-slope model is $$ Y_{ij}=\beta_0+\beta_1t_{ij}+b_{0i}+b_{1i}t_{ij}+\epsilon_{ij}. $$ Here $\beta_0,\beta_1$ are population-level intercept and slope; $b_{0i},b_{1i}$ are participant-specific deviations; and $\epsilon_{ij}$ is measurement error. A slope-based association model may include $$ h_i(t\mid b_i)=h_0(t)\exp\{\gamma^\mathsf{T}w_i+\alpha b_{1i}\}, $$ where $h_0(t)$ is the baseline hazard, $w_i$ are covariates, and $\alpha$ links the participant’s random slope to event hazard. Under this convention, $b_{1i}$ is a deviation from the population slope, not the total slope. If time is measured in years and the biomarker in units $U$, then $b_{1i}$ has units $U/\text{year}$, and $\alpha$ has units $\text{year}/U$.

For the simple calculations below, assume the measurement times are known, the biomarker follows a linear trajectory over the modeled period, and the errors are independent with mean zero and common variance $\sigma^2$, conditional on the random effects. The random effects are commonly modeled as having mean zero and a covariance matrix shared across participants. These assumptions make the basic timing comparison transparent; they are not guaranteed in real data. A nonlinear trajectory, correlated errors, or a visit process related to unobserved health can change the information available.

A timing-based assessment also presumes that the visits used are relevant to the outcome model—for example, measurements are taken before the event for participants who experience it. Whether outcome follow-up supplies enough additional information is a separate question.

Time Spread and Slope Information

Consider first one participant’s linear regression with an intercept and independent errors of variance $\sigma^2$. With $m$ measurements at times $t_1,\ldots,t_m$, the least-squares slope estimate has conditional variance $$ \operatorname{Var}(\hat b_1\mid t_1,\ldots,t_m)=\frac{\sigma^2}{S_{tt}}, \qquad S_{tt}=\sum_{j=1}^m(t_j-\bar t)^2, \qquad \bar t=\frac{1}{m}\sum_{j=1}^m t_j. $$ Thus, more time spread means more slope information, while errors with greater variance mean less. Repeating a measurement at precisely the same time can improve knowledge of the biomarker level at that time, but it does not create time spread by itself.

The formula follows from the ordinary least-squares slope $\hat b_1=\sum_j(t_j-\bar t)Y_j/S_{tt}$. Substituting the linear model cancels the intercept because $\sum_j(t_j-\bar t)=0$. The error contribution is $\sum_j(t_j-\bar t)\epsilon_j/S_{tt}$; independence and common variance give its variance as $\sigma^2\sum_j(t_j-\bar t)^2/S_{tt}^2=\sigma^2/S_{tt}$. This calculation is a useful design diagnostic, not a complete analysis of a joint model with random effects and survival outcomes.

With a random intercept and slope, measurements from one participant share the same latent effects, and the uncertainty about the slope depends on both the visit times and the random-effects distribution. Under a Gaussian model, a useful way to express the conditional information is through the measurement design matrix $X_i$ and measurement-error covariance $R_i$: information about the participant’s coefficients is proportional to $X_i^\mathsf{T}R_i^{-1}X_i$. To distinguish slope from intercept, the time values must vary; if every time is identical, the intercept and slope columns cannot be separated by that participant’s measurements.

Key takeaway: The count of visits is not a substitute for the spread of visit times. A design with many measurements close together may estimate a local biomarker level well while estimating its rate of change poorly.

Worked Example: Same Number of Visits, Different Time Spread

Hypothetical design. Suppose a participant has three biomarker measurements, measurement-error standard deviation $\sigma=2$ units, and visits at either $0,0.2,0.4$ years or $0,1,2$ years. Compare the simple-model slope standard errors.

For visits at $0,0.2,0.4$, the mean time is $0.2$ years, so $S_{tt}=(-0.2)^2+0^2+(0.2)^2=0.08$ year$^2$. Therefore, $$ SE(\hat b_1)=\sqrt{\frac{2^2}{0.08}}=\sqrt{50}=7.071\ \text{units/year}. $$

For visits at $0,1,2$, the mean time is $1$ year and $S_{tt}=(-1)^2+0^2+1^2=2$ year$^2$. Therefore, $$ SE(\hat b_1)=\sqrt{\frac{2^2}{2}}=\sqrt{2}=1.414\ \text{units/year}. $$

Both designs have three measurements, but the spread-out schedule has $2/0.08=25$ times the $S_{tt}$, and its slope standard error is five times smaller. Under the stated simple model, the clustered schedule offers much less precise slope estimation. This comparison does not account for differences in event follow-up or other features of a full joint model.

Visit Count, Repetition, and Population-Level Estimation

A single participant’s slope may be imprecise even when the study can estimate a population-average trend from many participants. But a population-average slope is not the same quantity as the distribution of subject-specific slopes. To estimate random-slope variation, the study needs information about change across participants, not merely a precise common mean trend. If most participants have only one measurement, for example, their own within-person changes are not directly observed; any random-slope information then depends heavily on the model and the pattern of observations among other participants.

Adding visits can help in two ways: it can increase the time spread, and it can reduce noise through repeated observations at informative times. Adding visits at already crowded times mostly helps with the second. For independent errors and a fixed set of visit times, the direct slope information in the simple model is $S_{tt}/\sigma^2$. This makes clear why a design review should summarize both the number of measurements and the distribution of their times, rather than reporting only an average visit count.

Worked Example: Repeated Baseline Visits Versus a Later Visit

Hypothetical design. Compare three visits at $0,0,0.5$ years with three visits at $0,0.25,0.5$ years. Assume independent errors with standard deviation $1.5$ biomarker units. Both schedules include three measurements and the same latest visit.

For $0,0,0.5$, the mean time is $0.1667$ years. Hence $S_{tt}=(-0.1667)^2+(-0.1667)^2+(0.3333)^2$, approximately $0.1667$ year$^2$. The slope standard error is $$ SE(\hat b_1)=\sqrt{\frac{1.5^2}{0.1667}} =\sqrt{13.50}=3.674\ \text{units/year}. $$

For $0,0.25,0.5$, the mean time is $0.25$ years and $S_{tt}=(-0.25)^2+0^2+(0.25)^2=0.125$ year$^2$. Thus, $$ SE(\hat b_1)=\sqrt{\frac{1.5^2}{0.125}} =\sqrt{18}=4.243\ \text{units/year}. $$

In this particular comparison, the duplicated baseline measurements produce slightly greater $S_{tt}$, because the two observations at zero are relatively far from the mean time. It would be incorrect to claim that any repeated baseline visit must contain less slope information than every alternative schedule. The important quantity is the complete set of times: the first schedule has $0.1667/0.125=1.333$ times the simple-model information, with a standard error smaller by a factor of $\sqrt{1.333}=1.155$. However, both designs cover only half a year, so both may still provide weak information for a slow-changing biomarker. Practical assessment also needs the scale of expected change and measurement noise.

From Longitudinal Slopes to Survival Associations

When the hazard includes $\alpha b_{1i}$, uncertainty in $b_{1i}$ is relevant to estimating $\alpha$. If the observed biomarker trajectory gives little separation between plausible participant slopes, the data provide weak direct evidence about which latent slopes accompany earlier or later events. A model can still return a numerical estimate, but its apparent precision may rely strongly on distributional assumptions, the survival component, or other participants’ measurements.

The units also provide a useful check. If a one-unit increase in $b_{1i}$ means one additional biomarker unit per year, then $\exp(\alpha)$ is the hazard ratio for a one-unit-per-year increase in the random slope, conditional on the model’s other terms. It is not a causal effect merely because the longitudinal and event processes are modeled jointly.

Worked Example: Translating Slope Uncertainty to Design Information

Hypothetical comparison. Suppose the measurement-error standard deviation is $2$ biomarker units. A design provides $S_{tt}=0.5$ year$^2$ per participant, while a proposed schedule provides $S_{tt}=2$ year$^2$. Use the simple linear model to compare slope standard errors and explain the implication for a slope-based association.

For the first schedule, $$ SE(\hat b_1)=\sqrt{\frac{2^2}{0.5}} =\sqrt{8}=2.828\ \text{units/year}. $$ For the proposed schedule, $$ SE(\hat b_1)=\sqrt{\frac{2^2}{2}} =\sqrt{2}=1.414\ \text{units/year}. $$

The second schedule has four times the time-spread information and half the standard error in this approximation. If the survival model uses $\alpha b_{1i}$, more precise longitudinal slopes can make the latent slope contributions more distinguishable and may support estimation of $\alpha$. This calculation does not compute an uncertainty interval for $\alpha$: event outcomes, censoring, the hazard specification, and the random-effects distribution also contribute to that estimation.

Diagnostics, Alternatives, and Limitations

A design assessment should inspect visit times at both the study and participant levels. Useful summaries include the distribution of each participant’s number of measurements, each participant’s time range, the proportion with at least two distinct times, and the distribution of $S_{tt}$. A study-wide mean follow-up time can conceal the fact that many participants have only baseline measurements or visits tightly clustered in time.

Little within-person time spread: many small $S_{tt}$ values indicate that individual slopes are likely to be noisy under the simple model.
Few participants with repeated distinct times: the data may have limited direct support for separating random slopes from random intercepts.
Large measurement error or strong residual correlation: the simple calculation can overstate effective information. With correlated errors, use the covariance structure rather than treating repeated measurements as independent.
Visits concentrated before an early event: some participants may not have later measurements. Do not treat a planned schedule as if every participant completed it; assess the observed, pre-event measurement times as well.
Nonlinear biomarker trajectories: a straight-line slope may summarize change poorly, and adding curvature terms requires additional time coverage and model justification.

A random-intercept-only model avoids estimating subject-specific slopes, but it cannot answer a question about slope-based association. Treating individual ordinary least-squares slopes as known covariates in a survival model is another tempting alternative; it ignores their estimation error and can distort association estimates. A joint random-slope model represents slopes as latent quantities, but does not manufacture information absent from the measurement schedule. More flexible longitudinal trajectories may be appropriate when linearity is implausible, but they generally require richer temporal coverage rather than solving sparse timing by themselves.

The $S_{tt}$ calculation is a screening tool, not a universal threshold. No single minimum value guarantees identifiability: the adequacy depends on biomarker units, measurement error, random-slope variation, sample size, visit patterns, and the survival data. Centering time can make the intercept refer to a meaningful time and can improve interpretation, but shifting the origin does not create additional time spread or change the underlying ability to distinguish a linear slope from an intercept.

Common Mistake

Pitfall: “There are five biomarker visits per participant, so random slopes must be well estimated.” The count alone does not establish this. Five visits within a very short interval can have less slope information than three visits spanning a longer interval. Check distinct visit times and their spread, then consider measurement error and whether enough participants contribute informative trajectories. Even a well-supported longitudinal slope does not by itself guarantee a well-supported slope–hazard association.

Check Your Understanding

Use the stated assumptions for the simple slope calculations. Answers are given after the questions.

For visits at $0,1,3$ years, calculate $S_{tt}$.
If $S_{tt}$ is multiplied by four while $\sigma$ stays fixed, what happens to the slope standard error?
Why can two measurements at the same time help estimate a biomarker level but fail to provide a new time contrast?
What additional information, beyond precise longitudinal slopes, is needed to estimate a slope-based survival association?

Solutions. (1) The mean time is $4/3$ years, so $S_{tt}=(-4/3)^2+(-1/3)^2+(5/3)^2=42/9=4.667$ year$^2$. (2) Since $SE(\hat b_1)=\sigma/\sqrt{S_{tt}}$, multiplying $S_{tt}$ by four halves the standard error. (3) Replicates at one time can reduce uncertainty about the level there, but their time deviations do not create additional distinct-time information; the slope depends on contrasts across times. (4) Estimation also depends on event outcomes and follow-up, censoring, the hazard specification, and the random-effects and measurement models.